The worldwide burden of cancer will fall primarily to low- and middle-income countries over the next decade, with 23.6 million cases predicted worldwide by 2030. Researchers project that between 10 and 11 million cases per year will occur in the developing world, where proper diagnosis and treatment are expensive and scarce. Chronic myeloid leukemia (CML), can be successfully treated with a single drug, but only if it is diagnosed. Without a diagnosis and treatment, most people succumb to the disease within 10 years. Spot on CML provides low-cost, low-tech access to advanced laboratory diagnostics for CML – and access to free life-saving treatment – through a unique collaboration that reaches patients across the globe.
The Max Foundation works with partner physicians to identify patients in need of diagnosis.
Fred Hutch provides Spot On CML test cards to the Max Foundation, who delivers or mails them to physicians.
The physician draws the patient’s blood and places four drops on the test card.